Published in Br J Cancer on August 31, 2010
Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res (2014) 2.51
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol (2015) 1.65
Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci (2012) 1.65
Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol (2014) 1.57
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol (2011) 1.41
Trial Watch: Monoclonal antibodies in cancer therapy. Oncoimmunology (2012) 1.34
New insights into the biology of renal cell carcinoma. Hematol Oncol Clin North Am (2011) 1.31
Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res (2013) 1.26
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res (2011) 1.23
Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clin Cancer Res (2014) 1.17
Interleukins in glioblastoma pathophysiology: implications for therapy. Br J Pharmacol (2013) 1.07
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood (2014) 1.02
The role of the T cell in age-related inflammation. Age (Dordr) (2012) 1.00
Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma. PLoS One (2013) 0.95
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells (2014) 0.93
Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm. Mol Cancer Ther (2012) 0.91
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer. Invest New Drugs (2012) 0.91
Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment. Cancer Microenviron (2012) 0.86
The immune system in the pathogenesis of ovarian cancer. Crit Rev Immunol (2013) 0.86
Retracted Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev (2015) 0.84
Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. BMC Cancer (2015) 0.84
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer. Oncotarget (2016) 0.83
Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer. Cancer (2013) 0.83
High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Cancer Sci (2015) 0.80
Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors. Mediators Inflamm (2016) 0.77
Type I IFN gene delivery suppresses regulatory T cells within tumors. Cancer Gene Ther (2014) 0.77
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology (2015) 0.77
Siltuximab (CNTO 328): a promising option for human malignancies. Drug Des Devel Ther (2015) 0.76
Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys. Nucleic Acid Ther (2015) 0.76
Targeted FcγR mediated clearance by a biparatopic bispecific antibody. J Biol Chem (2017) 0.75
Is immunotherapy re-entering the kidney cancer arena from the back door? Considerations from the Phase I/II study of siltuximab. Immunotherapy (2011) 0.75
Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature. CEN Case Rep (2013) 0.75
Interleukin-6 promotes tumor progression in colitis-associated colorectal cancer through HIF-1α regulation. Oncol Lett (2016) 0.75
Process of hepatic metastasis from pancreatic cancer: biology with clinical significance. J Cancer Res Clin Oncol (2015) 0.75
Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells. Crit Rev Immunol (2016) 0.75
Stromal characteristics may hold the key to mammographic density: the evidence to date. Oncotarget (2016) 0.75
Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. Oncotarget (2015) 0.75
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor. Semin Cancer Biol (2017) 0.75
IL-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci (2017) 0.75
Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy. PLoS One (2017) 0.75
Tumor-related interleukins: old validated targets for new anti-cancer drug development. Mol Cancer (2017) 0.75
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med (2007) 39.39
Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med (2007) 30.94
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med (2007) 24.19
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet (2007) 15.92
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol (2004) 4.68
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res (1992) 2.64
Targeted therapy for metastatic renal cell carcinoma. J Clin Oncol (2006) 2.50
The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep (2002) 2.47
Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer (2003) 2.18
Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie. J Clin Oncol (2004) 2.05
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer (1997) 1.70
Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). J Support Oncol (2006) 1.61
Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol (2003) 1.52
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell (2007) 1.45
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer (2007) 1.43
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology (2001) 1.37
Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol (2003) 1.22
CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice. Int J Cancer (2004) 1.21
Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments. Blood (1995) 1.20
Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group. Blood (1995) 1.20
Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma. Clin Cancer Res (2010) 1.13
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study. Br J Haematol (1998) 1.05
Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop. J Clin Invest (1996) 1.00
Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology (2003) 0.98
Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. Eur J Cancer (1997) 0.95
Therapeutic options in the management of renal cell carcinoma. Semin Oncol (2002) 0.92
Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis. J Clin Invest (2000) 0.92
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6. Clin Exp Immunol (1994) 0.90
Pretreatment serum markers and lymphocyte response to interleukin-2 therapy. Br J Cancer (1999) 0.85
Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice. J Urol (1995) 0.83
Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma. J Clin Oncol (2005) 0.83
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa. Bull World Health Organ (1973) 12.31
Genomics. Genome project standards in a new era of sequencing. Science (2009) 7.72
Impact of a patient-centered, computer-based health information/support system. Am J Prev Med (1999) 6.60
Effect of computer support on younger women with breast cancer. J Gen Intern Med (2001) 5.12
A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci U S A (2001) 4.69
Developing information materials to present the findings of technology assessments to consumers. The experience of the NHS Centre for Reviews and Dissemination. Int J Technol Assess Health Care (1998) 4.49
Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst (1999) 3.75
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 3.37
An active process in cochlear mechanics. Hear Res (1983) 3.33
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J Infect Dis (1998) 3.28
Polyphosphoprotein from the adhesive pads of Mytilus edulis. Biochemistry (2001) 3.05
Occupational asthma in an electronics factory. Thorax (1979) 3.03
Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care. BMJ (2001) 2.71
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.53
Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A (2001) 2.32
Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care. BMJ (2001) 2.30
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect Immun (2000) 2.09
Experiences of women with breast cancer: exchanging social support over the CHESS computer network. J Health Commun (2000) 2.08
A longitudinal study of possible allergy to enzyme detergents. Clin Allergy (1985) 2.07
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol (2010) 2.06
Prospective evaluation of treatment of Hemophilus influenzae meningitis. J Pediatr (1976) 1.99
Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings. Thorax (1977) 1.98
Psychosocial implications of strabismus surgery in adults. J Pediatr Ophthalmol Strabismus (1997) 1.91
Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect Immun (2000) 1.91
A model for transducer action in the cochlea. Cold Spring Harb Symp Quant Biol (1965) 1.90
Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br Med J (Clin Res Ed) (1985) 1.89
Workplace homicides of Texas males. Am J Public Health (1987) 1.89
Computer support for elderly women with breast cancer. JAMA (1998) 1.86
Respiratory symptoms, lung function, and sensitisation to flour in a British bakery. Br J Ind Med (1989) 1.85
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol (1997) 1.77
Occupational asthma in an electronics factory: a case control study to evaluate aetiological factors. Thorax (1979) 1.77
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial. Ann Oncol (2013) 1.76
Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia (2002) 1.72
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer (1997) 1.70
Characterization of a novel carotenoid cleavage dioxygenase from plants. J Biol Chem (2001) 1.69
Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med (1984) 1.69
Antecedents of low birthweight in Harlem, New York City. Int J Epidemiol (1972) 1.68
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
S-RNase uptake by compatible pollen tubes in gametophytic self-incompatibility. Nature (2000) 1.65
Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res (2001) 1.64
A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res (1998) 1.60
The temporal relationship between increases in airway responsiveness to histamine and late asthmatic responses induced by occupational agents. J Allergy Clin Immunol (1987) 1.57
Accuracy of fourth- and fifth-grade students' food records compared with school-lunch observations. Am J Clin Nutr (1994) 1.54
Measuring fruit and vegetable preferences among 4th- and 5th-grade students. Prev Med (1993) 1.54
Assessing how well three evaluation methods detect deficiencies in medical students' professionalism in two settings of an internal medicine clerkship. Acad Med (2000) 1.54
Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients. Arthritis Rheum (1993) 1.52
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol (2013) 1.51
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Ann Oncol (2008) 1.50
Conditioned suppression under positive, negative, and no contingency between conditioned and unconditioned stimuli. J Exp Anal Behav (1969) 1.50
Outcome of asthma induced by isocyanates. Br J Dis Chest (1987) 1.50
The Football Association Medical Research Programme: an audit of injuries in professional football-analysis of preseason injuries. Br J Sports Med (2002) 1.48
Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med (1996) 1.48
Frisby Davis distance stereoacuity values in visually normal children. Br J Ophthalmol (2005) 1.47
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy. BJU Int (2000) 1.47
A descriptive study of the role of the oncology nurse practitioner. Oncol Nurs Forum (1997) 1.46
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A (1999) 1.46
Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results. Arch Surg (1995) 1.45
Ethnicity, gender, family history of myocardial infarction, and hemodynamic responses to laboratory stressors in children. Health Psychol (1993) 1.44
Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci (2004) 1.44
Isolation and characterization of a carboxysome shell gene from Thiobacillus neapolitanus. Mol Microbiol (1994) 1.43
Prospective evaluation of accuracy, precision, and reproducibility of an at-home hemoglobin A1c sampling kit. Diabetes Technol Ther (1999) 1.42
Oblique double layers: a comparison between terrestrial and auroral measurements. Phys Rev Lett (2009) 1.42
A prospective analysis of intramuscular meperidine, promethazine, and chlorpromazine in pediatric emergency department patients. Ann Emerg Med (1991) 1.42
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial. Clin Oncol (R Coll Radiol) (2008) 1.42
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? Ann Oncol (2010) 1.41
The early posthospital phase of myocardial infarction. Prognostic stratification. Circulation (1976) 1.41
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial. Ann Oncol (2014) 1.39
Mycosis Fungoides. Proc R Soc Med (1914) 1.39
Some interactions of the vertex potentials. Electroencephalogr Clin Neurophysiol (1968) 1.38
Prostate cancer--what should be studied? Eur J Cancer (1995) 1.38
CHANGES IN HUMAN BRAIN POTENTIALS DURING THE ONSET OF SLEEP. Science (1937) 1.37
Principles of electric response audiometry. Ann Otol Rhinol Laryngol (1976) 1.37
Occupational asthma in a research centre breeding locusts. Clin Allergy (1980) 1.36
A slow brain stem response for low-frequency audiometry. Audiology (1980) 1.36
Effects of duration and rise time of tone bursts on evoked V potentials. J Acoust Soc Am (1968) 1.34
The slow response of the human cortex to auditory stimuli: recovery process. Electroencephalogr Clin Neurophysiol (1966) 1.34
Effects of Theraband and lightweight dumbbell training on shoulder rotation torque and serve performance in college tennis players. Am J Sports Med (1998) 1.31
The Football Association Medical Research Programme: an audit of injuries in professional football: an analysis of ankle sprains. Br J Sports Med (2003) 1.31
Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody. J Allergy Clin Immunol (1983) 1.31
Rejection of S-heteroallelic pollen by a dual-specific s-RNase in Solanum chacoense predicts a multimeric SI pollen component. Genetics (2001) 1.30
Occupational asthma in a factory making flux-cored solder containing colophony. Thorax (1981) 1.29
Auditory brainstem responses in preterm neonates: maturation and follow-up. J Pediatr (1982) 1.29
Control of sexually transmitted diseases in Haiti: results and implications of a baseline study among pregnant women living in Cité Soleil Shantytowns. J Infect Dis (1995) 1.23
Depriving rats of food: A reappraisal of two techniques. J Exp Anal Behav (1983) 1.21
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer (2004) 1.21
Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol (1997) 1.18
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. Ann Oncol (2008) 1.18
Long-term evaluation of pylorus preservation during pancreaticoduodenectomy. World J Surg (1988) 1.17
An improved training procedure as a precursor to testing young children with the Frisby Stereotest. Eye (Lond) (1996) 1.16
Evaluation of the Children's Activity Rating Scale (CARS) in young children. Med Sci Sports Exerc (1993) 1.16
Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr Metab Cardiovasc Dis (2009) 1.16
An encephalomyocarditis virus epizootic in a baboon colony. Lab Anim Sci (1992) 1.16
Acute effects of transcendental meditation on hemodynamic functioning in middle-aged adults. Psychosom Med (1999) 1.15
Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol (1995) 1.14